Millions of Medicare beneficiaries could soon see a dramatic drop in the cost of popular GLP‑1 weight‑loss drugs, with out‑of‑pocket prices falling to $50 a month—a decrease of roughly 95 percent or more. The change comes through a newly unveiled GLP‑1 Bridge pilot program, which for the first time would allow Medicare to broadly cover weight‑loss versions of GLP‑1 medications, such as Wegovy. Until now, GLP‑1 weight‑loss drugs have been widely seen as out of reach for many seniors, with